5 teachers of IIT Palakkad feature among world's top 2% scientists thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.
It looks like the more we learn about the China-produced COVID-19 virus, the worse the news gets. According to the largest study of its kind, contracting COVID-19 may increase the risk of [.]
TECHIN signs up with West Pharma to launch The MedTech Research Center of Excellence laosnews.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from laosnews.net Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
PROVIDENCE, R.I., Feb. 17, 2021 /PRNewswire/ EpiVax, Inc. ( EpiVax ) today announces its participation in the INDIGO consortium – a partnership of public and private research and development organizations from the EU, India, and United States (funded by the EU and India) with the aim of developing next-generation influenza vaccines with better responsiveness, lower costs, and better accessibility.
The INDIGO consortium, led by Dr. Remko van Leeuwen (INDIGO s Principal Investigator) of the Amsterdam Institute for Global Health and Development ( AIGHD ), plans to achieve this goal by exploring innovative influenza vaccine concepts. The group will aim to produce novel seasonal (A and B) and avian flu (H7N9 and H5N1) vaccines by combining three cutting-edge elements: novel recombinant HAs with increased immunogenicity, a potent adjuvant, and delivery via needle-free intradermal patches. The consortium will seek to validate this approach by sh